This trial is evaluating whether Treatment will improve 3 primary outcomes and 18 secondary outcomes in patients with Autoimmune Diseases. Measurement will happen over the course of Change from baseline at 12 months.
This trial requires 400 total participants across 0 different treatment group
Patients from any state can participate in this trial, so long as they are able to attend all treatment sessions.
In order to understand how insurance coverage works for this trial, you will need to contact the study coordinator.